Bone sialoprotein, matrix metalloproteinase 2, and αvβ3 integrin in osteotropic cancer cell invasion

被引:94
作者
Karadag, A
Ogbureke, KUE
Fedarko, NS
Fisher, LW
机构
[1] NIDCR, Craniofacial & Skeletal Dis Branch, US Dept HHS, NIH, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr, Baltimore, MD 21205 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 12期
关键词
D O I
10.1093/jnci/djh169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Bone sialoprotein (BSP) interacts separately with both matrix metalloproteinase 2 (MMP-2) and integrin alpha(v)beta(3) and is overexpressed in many metastatic tumors. Its role in tumor biology, however, remains unclear. We investigated whether BSP enhances cancer cell invasiveness by forming a trimolecular complex with MMP-2 and cell-surface integrin alpha(v)beta(3). Methods: Invasiveness of breast, prostate, lung, and thyroid tumor cell lines was measured with a modified Boyden chamber assay. Binding and co-localization of BSP, MMP-2, and integrin alpha(v)beta(3) were investigated with immunoprecipitation and in situ hybridization. All statistical tests were two-sided. Results.. Treatment with BSP increased invasiveness of many breast, prostate, lung, and thyroid cancer cells through Matrigel in a dose-dependent manner. BSP at 50 nM increased the invasiveness of SW-579 thyroid cancer cells (95.2 units, 95% confidence interval [CI] = 90.4 to 100 units) by approximately 10-fold compared with that of untreated control SW-579 cells (9.1 units, 95% CI = 5.7 to 12.5 units) (P<.001). Addition of an inactive mutated BSP, in which BSP's integrin-binding RGD tripeptide was altered, or addition of integrin alpha(v)beta(3)-blocking antibodies resulted in invasiveness equivalent to that of untreated cells. Inhibiting cellular MMP-2 activity with chemical inhibitors or a specific antibody also blocked BSP-enhanced invasiveness. Osteopontin and dentin matrix protein 1, proteins related to BSP that also bind integrin alpha(v)beta(3) and form complexes with other MMPs (but not MMP-2), did not enhance invasiveness. Immunoprecipitation showed that a complex containing BSP, integrin alpha(v)beta(3), and MMP-2 formed in vitro. Addition of BSP increased the amount of MMP-2 bound by cells in an integrin-dependent fashion. Co-expression of BSP, integrin alpha(v)beta(3), and MMP-2 in papillary thyroid carcinoma cells was shown by in situ hybridization. Conclusion: Cancer cells appear to become more invasive when BSP forms a cell-surface trimolecular complex by linking MMP-2 to integrin alpha(v)beta(3). [J Natl Cancer Inst 2004;96:956-65]
引用
收藏
页码:956 / 965
页数:10
相关论文
共 59 条
[41]   Refined mapping of the human dentin sialophosphoprotein (DSPP) gene within the critical dentinogenesis imperfecta type II and dentin dysplasia type II loci [J].
MacDougall, M .
EUROPEAN JOURNAL OF ORAL SCIENCES, 1998, 106 :227-233
[42]   Cancer biology: Extracellular proteinases in malignancy [J].
Matrisian, LM .
CURRENT BIOLOGY, 1999, 9 (20) :R776-R778
[43]  
MONTEAGUDO C, 1990, AM J PATHOL, V136, P585
[44]  
OLDBERG A, 1988, J BIOL CHEM, V263, P19433
[45]   REGULATED EXPRESSION OF OSTEOPONTIN IN HUMAN TROPHOBLASTS [J].
OMIGBODUN, A ;
DAITER, E ;
WALINSKY, D ;
FISHER, L ;
YOUNG, M ;
HOYER, J ;
COUTIFARIS, C .
OSTEOPONTIN: ROLE IN CELL SIGNALLING AND ADHESION, 1995, 760 :346-349
[46]  
PYKE C, 1992, CANCER RES, V52, P1336
[47]  
RIMINUCCI M, 2003, CALCIF TISSUE INT
[48]  
Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO
[49]  
2-K
[50]  
Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO